Trelleborg is known for supplying original equipment manufacturers and pharmaceutical companies with high quality tubing and tubing, such as its PharmaTube platinum silicone tubing for single-use and multi-use pharmaceutical applications. The company’s portfolio also includes a wide range of O-rings, seals, bearings and composite products.
Last year, the company expanded its milling and extrusion capabilities at the site, and now the three-phase expansion project in Northborough will bring capacity and capacity gradually online over the next 24-36 months. , with Phase 1 starting in January 2023. The expansion is expected to create at least 50 new jobs.
Linda Muroski, President of Trelleborg Healthcare & Medical, said: “The site will increase our Class 7 and 8 cleanroom manufacturing capabilities by 25,000 square feet.2to meet growing market demand for biopharmaceutical applications, such as silicone tubing and tubing, assemblies and other integrated solutions.
“This investment is a key step in our global biopharmaceutical strategy and will allow us to expand our offerings to existing and new customers in the industry. Our customers need a global partner for their growth, and we are committed to being that partner.
Florance Veronelli, Head of Global Business Development for Biopharma, added: “The expansion will allow us to increase our manufacturing capabilities for extrusion and molding and offer enhanced flexible manufacturing solutions. As a full-service provider to the biopharmaceutical industry, our value-added offering will include assembly, kitting, contract manufacturing, packaging, validation, supply chain management, and more. .